Oslo, 28 May 2018. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this notification on behalf of its chairman, Hans Peter Bøhn.
Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 29 May 2018. Mr. Bøhn holds 83,556 shares, representing 0.3 per cent of the share capital of PCI Biotech. By close of business on 25 May 2018, Mr. Bøhn had received powers of attorney to represent and vote for 5,124,123 additional shares. In total, Mr. Bøhn will represent and vote for 20.8 per cent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 29 May 2018.
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CFO, firstname.lastname@example.org, Mobile: +47 9400 5757